Geron (GERN) Net Margin (2010 - 2026)

Geron's (GERN) quarterly Net Margin came in at 6.88% in Q1 2026, up 4299.0% year-on-year from 0.16% in Q1 2025, and down 123.04% quarter-over-quarter from 29.87% in Q4 2025.

Geron (GERN) Net Margin (2010 - 2026) Analysis & Trends

Geron has disclosed Net Margin across 17 years of filings, most recently posting 6.88% for Q1 2026.

  • Net Margin for Q1 2026 came in at 6.88%, up 4299.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 129.42% (down 1107.0% YoY), and the FY2025 annual result was 210.5%, up 1516.0% from the prior year.
  • Net Margin came in at 6.88% for Q1 2026 at Geron, down from 29.87% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 24305.61% in Q4 2023 to a low of 181719.05% in Q1 2023.
  • The 5-year median for Net Margin is 93.33% (2024), against an average of 26472.59%.
  • Across the five-year window, Net Margin plunged 15729466 bps in 2023 and surged 16351905 bps in 2024, its largest moves.
  • Geron's Net Margin stood at 8665.52% in 2022, then surged by 180 bps to 24305.61% in 2023, then slumped by 100 bps to 50.16% in 2024, then soared by 160 bps to 29.87% in 2025, then tumbled by 123 bps to 6.88% in 2026.
  • The last three Net Margin figures came in at 6.88% (Q1 2026), 29.87% (Q4 2025), and 38.68% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 34.53%
9 Abivax 91.71 Bn 91.71 Bn - -
10 Geron 729,618.77 729,618.77 - -6.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.88%
Dec 31, 2025 29.87%
Sep 30, 2025 -38.68%
Jun 30, 2025 -33.27%
Mar 31, 2025 -49.88%
Dec 31, 2024 -50.16%
Sep 30, 2024 -93.33%
Jun 30, 2024 -7,632.65%
Mar 31, 2024 -18,200.00%
Dec 31, 2023 24,305.61%
Sep 30, 2023 -27,264.02%
Jun 30, 2023 -169,710.34%
Mar 31, 2023 -181,719.05%
Dec 31, 2022 8,665.52%
Sep 30, 2022 -13,775.42%
Jun 30, 2022 -40,036.99%
Mar 31, 2022 -24,424.39%
Dec 31, 2021 -3,077.98%
Sep 30, 2021 -24,422.02%
Jun 30, 2021 -27,623.36%